{"id":"W4411554374","doi":"10.1007/s40268-025-00514-9","title":"Demonstrating Bioequivalence for a Lumacaftor Monosubstance Formulation Versus Orkambi® (Lumacaftor/Ivacaftor) in Healthy Subjects","year":2025,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ted Rogers Centre for Heart Research; Heart and Stroke Foundation; Micropharma (Canada); University of Toronto","funders":"","keywords":"Ivacaftor; Bioequivalence; Medicine; Pharmacology; Pharmacokinetics; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004402917,0.0004264094,0.0006350266,0.0002466191,0.0003123483,0.0005504314,0.0003478192,0.001000038,0.004319775],"category_scores_gemma":[0.002731373,0.0002168176,0.0004976777,0.0002287931,0.0005074904,0.000378899,0.0001925028,0.0006153352,0.0006764102],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002975761,"about_ca_system_score_gemma":0.0003986776,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004811213,"about_ca_topic_score_gemma":0.0004881849,"domain_scores_codex":[0.9983298,0.0009406641,0.000111438,0.0003046175,0.0002211324,0.00009238799],"domain_scores_gemma":[0.9988846,0.0003157461,0.0003962853,0.0001374248,0.000120434,0.0001455479],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.664363,0.01602438,0.01482137,0.0009915286,0.001128023,0.0002277213,0.0007175023,0.0005374285,0.2042293,0.0004639228,0.002597877,0.09389793],"study_design_scores_gemma":[0.05583523,0.6913999,0.1775208,0.0001422709,0.001705967,0.0009956565,0.0003564837,0.003719273,0.06088364,0.0002806621,0.007071577,0.00008854749],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9952651,0.0009278646,0.001174973,0.00007816245,0.0000844052,0.0008559121,0.0005738286,0.00004834149,0.0009913804],"genre_scores_gemma":[0.9961152,0.0002807265,0.00146267,0.0001255457,0.0000639789,0.0004469345,0.0004486538,0.00001484696,0.001041441],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004402917,"threshold_uncertainty_score":0.02328515,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03127630825639068,"score_gpt":0.3832231826700569,"score_spread":0.3519468744136663,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}